# A Pharmacokinetic Substudy of the TDE-PH-304 Protocol

> **NCT01934582** · PHASE3 · COMPLETED · sponsor: **United Therapeutics** · enrollment: 13 (actual)

## Conditions studied

- Pulmonary Arterial Hypertension

## Interventions

- **DRUG:** UT-15C SR
- **DRUG:** treprostinil diethanolamine

## Key facts

- **NCT ID:** NCT01934582
- **Lead sponsor:** United Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-08
- **Primary completion:** 2013-11
- **Final completion:** 2013-11
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2024-01-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01934582

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01934582, "A Pharmacokinetic Substudy of the TDE-PH-304 Protocol". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01934582. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*